Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 2 |
STJ
St Jude Medical
STJ
|
+$235M |
| 3 |
JPMorgan Chase
JPM
|
+$211M |
| 4 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACRE
4726
Ares Commercial Real Estate
ACRE
$236M
| $110K | ﹤0.01% |
8,248
+7,948
| +2,649% | +$107K |
|
4727
CALL
Alto Ingredients
ALTO
$377M
| $110K | ﹤0.01% |
16,000
+3,300
| +26% | +$25.1K |
|
4728
PUT
Avnet
AVT
$7.29B
| $110K | ﹤0.01% |
2,400
+1,500
| +167% | +$69.4K |
|
|
ELP
4729
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $110K | ﹤0.01% |
26,760
+11,360
| +74% | +$47K |
|
4730
Neogen
NEOG
$2.59B
| $110K | ﹤0.01% |
4,451
-1,674
| -27% | -$41K |
|
|
NEOS
4731
DELISTED
Neos Therapeutics, Inc
NEOS
| $110K | ﹤0.01% |
15,228
+11,266
| +284% | +$69.9K |
|
4732
PUT
Forestar Group
FOR
$1.47B
| $109K | ﹤0.01% |
8,000
-400
| -5% | -$5.24K |
|
4733
CALL
Molina Healthcare
MOH
$10.2B
| $109K | ﹤0.01% |
2,400
-1,700
| -41% | -$89K |
|
4734
CALL
Myriad Genetics
MYGN
$285M
| $109K | ﹤0.01% |
5,700
+300
| +6% | +$5.32K |
|
|
SGM
4735
DELISTED
Stonegate Mortgage Corporation
SGM
| $109K | ﹤0.01% |
+13,720
| New | +$101K |
|
4736
Compass Diversified
CODI
$795M
| $108K | ﹤0.01% |
+6,518
| New | +$111K |
|
4737
CALL
Designer Brands
DBI
$331M
| $108K | ﹤0.01% |
5,200
-15,500
| -75% | -$322K |
|
4738
CALL
O'Reilly Automotive
ORLY
$73.3B
| $108K | ﹤0.01% |
6,000
-66,000
| -92% | -$1.19M |
|
4739
Standard Motor Products
SMP
$863M
| $108K | ﹤0.01% |
2,205
+1,205
| +121% | +$59.7K |
|
|
ABB
4740
DELISTED
ABB Ltd
ABB
| $108K | ﹤0.01% |
4,600
-2,263
| -33% | -$51.7K |
|
|
GCAP
4741
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $108K | ﹤0.01% |
12,974
+12,719
| +4,988% | +$98.7K |
|
|
GNC
4742
PUT
DELISTED
GNC Holdings, Inc.
GNC
| $108K | ﹤0.01% |
14,700
-23,200
| -61% | -$200K |
|
4743
CALL
NiSource
NI
$21.3B
| $107K | ﹤0.01% |
4,500
+800
| +22% | +$18.3K |
|
|
SONC
4744
CALL
DELISTED
Sonic Corp
SONC
| $107K | ﹤0.01% |
4,200
+2,000
| +91% | +$50.5K |
|
4745
PUT
Albemarle
ALB
$14B
| $106K | ﹤0.01% |
+1,000
| New | +$97.3K |
|
4746
GSI Technology
GSIT
$233M
| $106K | ﹤0.01% |
+12,111
| New | +$83.4K |
|
4747
Idacorp
IDA
$8.32B
| $106K | ﹤0.01% |
1,277
-5,043
| -80% | -$406K |
|
|
PRO
4748
DELISTED
PROS Holdings
PRO
| $106K | ﹤0.01% |
4,340
-3,334
| -43% | -$75.3K |
|
4749
Rigel Pharmaceuticals
RIGL
$693M
| $106K | ﹤0.01% |
3,204
-1,227
| -28% | -$31.3K |
|
4750
Super Micro Computer
SMCI
$18.5B
| $106K | ﹤0.01% |
41,910
+28,180
| +205% | +$74.7K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.